NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 84 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,172,044 | +18.6% | 3,821,740 | 0.0% | 0.02% | +20.0% |
| Q1 2023 | $2,675,218 | +37.5% | 3,821,740 | 0.0% | 0.02% | +25.0% |
| Q4 2022 | $1,945,266 | -20.5% | 3,821,740 | 0.0% | 0.01% | -25.0% |
| Q3 2022 | $2,446,000 | -37.9% | 3,821,740 | 0.0% | 0.02% | -27.3% |
| Q2 2022 | $3,936,000 | -45.2% | 3,821,740 | 0.0% | 0.02% | -46.3% |
| Q1 2022 | $7,185,000 | -61.0% | 3,821,740 | 0.0% | 0.04% | -54.4% |
| Q4 2021 | $18,421,000 | -33.3% | 3,821,740 | 0.0% | 0.09% | -25.6% |
| Q3 2021 | $27,631,000 | -21.7% | 3,821,740 | 0.0% | 0.12% | -21.9% |
| Q2 2021 | $35,275,000 | -25.0% | 3,821,740 | 0.0% | 0.16% | -24.0% |
| Q1 2021 | $47,046,000 | -12.7% | 3,821,740 | 0.0% | 0.20% | +0.5% |
| Q4 2020 | $53,887,000 | +17.5% | 3,821,740 | 0.0% | 0.20% | +10.9% |
| Q3 2020 | $45,861,000 | -18.7% | 3,821,740 | +12.5% | 0.18% | -26.5% |
| Q2 2020 | $56,402,000 | +45.9% | 3,397,740 | 0.0% | 0.25% | +4.6% |
| Q1 2020 | $38,666,000 | -7.6% | 3,397,740 | 0.0% | 0.24% | +6.7% |
| Q4 2019 | $41,860,000 | +29.9% | 3,397,740 | -69.9% | 0.22% | +1.8% |
| Q3 2019 | $32,221,000 | – | 11,305,679 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|